7m
Hosted on MSNNevro upgraded to Neutral from Underweight at Piper SandlerPiper Sandler analyst Adam Maeder upgraded Nevro (NVRO) to Neutral from Underweight with a price target of $5.85, down from $6, after the company ...
Piper Sandler (PIPR) announced that its board of directors has authorized the repurchase of up to $150 million of the company’s outstanding ...
According to Piper Sandler, these factors have led to a slight revision of their forecasts for Uber, prompting the price target adjustment. Despite these concerns, the firm reiterated its Overweight ...
Piper Sandler restated their neutral rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a research report ...
Piper Sandler raised the firm’s price target on Kemper (KMPR) to $86 from $83 and keeps an Overweight rating on the shares following quarterly ...
Piper Sandler's research dated Feb. 4 has revealed a less optimistic outlook for Meta Platforms' position in the artificial intelligence race.
Piper Sandler restated their overweight rating on shares of The Cigna Group (NYSE:CI – Free Report) in a research note published on Monday morning,Benzinga reports. Piper Sandler currently has a $348.
Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional ...
Microsoft Corporation's cloud computing platform, Azure's workloads could push its artificial intelligence revenue to $10 ...
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of the company's outstanding common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results